COVID-19 pandemic and mental distress in multiple sclerosis: Implications for clinical management.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 08 06 2020
accepted: 04 10 2020
pubmed: 13 10 2020
medline: 22 9 2021
entrez: 12 10 2020
Statut: ppublish

Résumé

In multiple sclerosis (MS), disease-related factors and dysfunctional coping might favor the development of mental distress induced by COVID-19 containment measures. Aim of this study was exploring the relationship between disability, coping strategies, daily life reorganization and neuropsychiatric symptoms in an Italian MS population during the COVID-19 lockdown, in order to identify potentially modifiable factors that could inform clinical management of mental distress in people with MS. We explored the relationship between mental distress, disability and coping strategies in the Italian MS population under lockdown. Structural equation modeling was applied to information collected via web survey to identify modifiable factors that could account for mental distress. A total of 845 participants (497 with MS and 348 controls) were included in the study. The MS group had higher scores than the control group for depression (p = 0.005), but not for anxiety, emotional dyscontrol or sleep disturbances. The structural equation modeling explained 74% of the variance observed in depression score. Within the model, three latent factors were characterized from measured variables: motor disability and cognitive dysfunction contributed to disability (β = 0.509 and β = 0.836; p < 0.001); positive attitude and exercise contributed to active attitude (β = 0.386 and β = 0.297; p < 0.001); and avoidance, social support and watching television contributed to passive attitude (β = 0.301, β = 0.243 and β = 0.212; p < 0.001). With regard to the relationship between latent factors and their influence on depression, disability contributed to passive attitude (β = 0.855; p < 0.001), while both passive and active attitude significantly influenced depression (β = 0.729 and β = -0.456; p < 0.001). As a practical implication of our model, favoring exercise would enhance active attitude and its positive impact on mental well-being while, at the same time, reducing the negative impact of disability on depression, representing a valuable tool in facing COVID-19-related mental distress.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
In multiple sclerosis (MS), disease-related factors and dysfunctional coping might favor the development of mental distress induced by COVID-19 containment measures. Aim of this study was exploring the relationship between disability, coping strategies, daily life reorganization and neuropsychiatric symptoms in an Italian MS population during the COVID-19 lockdown, in order to identify potentially modifiable factors that could inform clinical management of mental distress in people with MS.
METHODS METHODS
We explored the relationship between mental distress, disability and coping strategies in the Italian MS population under lockdown. Structural equation modeling was applied to information collected via web survey to identify modifiable factors that could account for mental distress.
RESULTS RESULTS
A total of 845 participants (497 with MS and 348 controls) were included in the study. The MS group had higher scores than the control group for depression (p = 0.005), but not for anxiety, emotional dyscontrol or sleep disturbances. The structural equation modeling explained 74% of the variance observed in depression score. Within the model, three latent factors were characterized from measured variables: motor disability and cognitive dysfunction contributed to disability (β = 0.509 and β = 0.836; p < 0.001); positive attitude and exercise contributed to active attitude (β = 0.386 and β = 0.297; p < 0.001); and avoidance, social support and watching television contributed to passive attitude (β = 0.301, β = 0.243 and β = 0.212; p < 0.001). With regard to the relationship between latent factors and their influence on depression, disability contributed to passive attitude (β = 0.855; p < 0.001), while both passive and active attitude significantly influenced depression (β = 0.729 and β = -0.456; p < 0.001).
CONCLUSION CONCLUSIONS
As a practical implication of our model, favoring exercise would enhance active attitude and its positive impact on mental well-being while, at the same time, reducing the negative impact of disability on depression, representing a valuable tool in facing COVID-19-related mental distress.

Identifiants

pubmed: 33043560
doi: 10.1111/ene.14580
pmc: PMC7675416
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3375-3383

Informations de copyright

© 2021 European Academy of Neurology.

Références

Int J Environ Res Public Health. 2020 May 02;17(9):
pubmed: 32370116
Eur J Neurol. 2021 Oct;28(10):3375-3383
pubmed: 33043560
Neurol Neuroimmunol Neuroinflamm. 2020 May 15;7(4):
pubmed: 32414755
Mult Scler Relat Disord. 2019 Jan;27:214-222
pubmed: 30412819
Psychiatry Res. 2020 Jun;288:112958
pubmed: 32283450
Compr Psychiatry. 2018 Nov;87:123-127
pubmed: 30343247
Mult Scler Relat Disord. 2017 Nov;18:173-176
pubmed: 29141804
Acta Neurol Belg. 2021 Apr;121(2):465-471
pubmed: 31571134
Emerg Infect Dis. 2004 Jul;10(7):1206-12
pubmed: 15324539
Neurol Sci. 2020 May;41(5):1007-1009
pubmed: 32303856
Neurology. 2020 Jun 2;94(22):949-952
pubmed: 32241953
Lancet Neurol. 2020 Jun;19(6):481-482
pubmed: 32359409
Psychol Med. 2021 Apr;51(6):1054-1056
pubmed: 32423496
Eur J Neurol. 2020 Sep;27(9):e50-e51
pubmed: 32402100
Mult Scler. 1999 Oct;5(5):349-54
pubmed: 10516779
Nat Rev Neurol. 2014 Sep;10(9):507-17
pubmed: 25112509
Mult Scler Relat Disord. 2020 Jun;41:102164
pubmed: 32388452
Epilepsia. 2020 Jun;61(6):1166-1173
pubmed: 32353184
Mult Scler. 2009 Dec;15(12):1495-501
pubmed: 19965515
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
Mult Scler Relat Disord. 2020 Oct;45:102407
pubmed: 32702641
Expert Rev Neurother. 2019 Apr;19(4):333-347
pubmed: 30829076
Neurology. 1995 Feb;45(2):251-5
pubmed: 7854521
J Palliat Med. 2020 Jul;23(7):888-889
pubmed: 32408790
J Neurol. 2021 May;268(5):1598-1607
pubmed: 32813051
Mult Scler Relat Disord. 2020 Oct;45:102452
pubmed: 32823148
Mult Scler Relat Disord. 2018 Apr;21:108-109
pubmed: 29547779
Interact J Med Res. 2017 Jul 14;6(2):e10
pubmed: 28710056
J Neurol. 2021 Mar;268(3):743-750
pubmed: 32725312
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Med Sci Sports Exerc. 2017 Jun;49(6):1184-1189
pubmed: 28121803
Annu Rev Psychol. 2010;61:679-704
pubmed: 19572784
Mult Scler Relat Disord. 2016 Nov;10:145-168
pubmed: 27919483
Neurol Sci. 2010 Nov;31(Suppl 2):S227-30
pubmed: 20640468
Neurology. 2012 Jun 5;78(23):1860-7
pubmed: 22573626
Mult Scler Relat Disord. 2020 Apr;39:102073
pubmed: 32334820
Brain Behav Immun. 2020 Jul;87:75-79
pubmed: 32325098
Mult Scler. 2018 Nov;24(13):1657-1664
pubmed: 30231004
Cochrane Database Syst Rev. 2019 Jan 14;1:CD012732
pubmed: 30637728

Auteurs

Teresa Costabile (T)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Antonio Carotenuto (A)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Luigi Lavorgna (L)

Second Division of Neurology, Multiple Sclerosis Center, University of Campania Luigi Vanvitelli, Naples, Italy.

Giovanna Borriello (G)

MS Center, S. Andrea Hospital, Sapienza University, Rome, Italy.

Lucia Moiola (L)

Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Matilde Inglese (M)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Ospedale Policlinico San Martino IRCCS, Genoa, Italy.

Martina Petruzzo (M)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Francesca Trojsi (F)

Second Division of Neurology, Multiple Sclerosis Center, University of Campania Luigi Vanvitelli, Naples, Italy.

Antonio Ianniello (A)

MS Center, S. Andrea Hospital, Sapienza University, Rome, Italy.

Agostino Nozzolillo (A)

Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Maria Cellerino (M)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.

Giacomo Boffa (G)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.

Laura Rosa (L)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Giuseppe Servillo (G)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Marcello Moccia (M)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Simona Bonavita (S)

Second Division of Neurology, Multiple Sclerosis Center, University of Campania Luigi Vanvitelli, Naples, Italy.

Massimo Filippi (M)

Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Neuroimaging Research Unit, Division of Neuroscience, Institute of Experimental Neurology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Vita-Salute San Raffaele University, Milan, Italy.

Roberta Lanzillo (R)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Vincenzo Brescia Morra (V)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Maria Petracca (M)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH